SSYS scores in the low-to-mid range primarily due to persistent revenue declines and GAAP losses despite a strong balance sheet and improving operating cash flow. Technical indicators are bearish with the stock trading below key moving averages, while valuation offers limited support given negative earnings and no dividend. The earnings call adds some offsetting optimism via 2026 sequential-growth guidance, cost discipline, and strategic customer wins, but headwinds and continued GAAP losses keep the overall score constrained.
Positive Factors
Balance Sheet Strength
Large cash resources and minimal leverage create durable financial optionality. With ~$244M in liquidity, Stratasys can fund R&D, absorb cyclical demand, execute targeted M&A or sustain operations during slow system cycles without immediate refinancing risk, supporting multi‑quarter strategic plans.
Negative Factors
Multi-year Revenue Decline
Persistent revenue contraction over several years signals weakened end‑market demand or competitive/price pressure. Shrinking top line limits operating leverage, reduces scale economics for materials and services, and makes it harder to recover fixed costs, constraining durable margin improvement and growth options.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance Sheet Strength
Large cash resources and minimal leverage create durable financial optionality. With ~$244M in liquidity, Stratasys can fund R&D, absorb cyclical demand, execute targeted M&A or sustain operations during slow system cycles without immediate refinancing risk, supporting multi‑quarter strategic plans.
Stratasys Ltd. provides connected polymer-based 3D printing solutions. It offers 3D printing systems, such as polyjet printers, FDM printers, stereolithography printing systems, and programmable photo polymerization printers for rapid prototyping,...
Read more
How the Company Makes Money
Stratasys primarily makes money by selling (1) 3D printing systems (hardware) and (2) recurring consumables and support tied to the installed base. Key revenue streams include: (a) Printer/system sales: One-time revenue from the sale of industrial...
Read more
Stratasys Key Performance Indicators (KPIs)
Any
Any
Revenue by Segment
Revenue by Segment Breaks down income from various business units, highlighting which segments are performing well and contributing most to overall growth.
Chart InsightsStratasys is experiencing a decline in both Products and Services revenue, with macroeconomic pressures and increased tariffs impacting sales. Despite a 2.1% drop in consolidated revenue, the company is focusing on strategic investments in high-value verticals like aerospace and defense, which are showing strong hardware sales. The dental sector is also a key growth area, supported by new leadership and product innovations. Cost management efforts are evident, but challenges remain with declining gross margins and macro-driven spending constraints.
The call presented a mixed but resilient picture: clear operational discipline, meaningful strategic wins (notably in aerospace/defense and automotive), expanding manufacturing mix, improved full-year adjusted EBITDA and cash generation, and a conservative but growth-oriented 2026 outlook. Offsetting these positives were continued year-over-year revenue declines, notable margin compression primarily driven by tariffs, FX and mix, ongoing GAAP losses, and sensitivity to government and capital-spend cycles. Management emphasized cost controls, a strong balance sheet and pathway to sequential growth in 2026, but also included conservative adjustments for FX/tariffs in guidance.
Positive Updates
Manufacturing Mix Expansion
Manufacturing accounted for 37.5% of revenues in 2025, up from 36% in 2024 and from just over 25% in 2020 — demonstrating multi-year progress toward higher-value, higher-utilization production applications.
Negative Updates
Year-over-Year Revenue Decline
Consolidated revenue declined to $140.0M in Q4 (down 6.9% YoY) and full-year revenue fell to $551.1M from $572.5M in 2024 (down ~3.7% YoY). Product revenue and services also declined on a full-year basis.
Read all updates
Q4-2025 Updates
Positive
Negative
Manufacturing Mix Expansion
Manufacturing accounted for 37.5% of revenues in 2025, up from 36% in 2024 and from just over 25% in 2020 — demonstrating multi-year progress toward higher-value, higher-utilization production applications.
Read all positive updates
Company Guidance
Stratasys guided 2026 revenue of $565–575 million with sequential quarterly growth and higher revenue in the second half (Q1 expected to be the weakest for revenue and margins), and said consumables revenue should increase versus 2025; it expects non‑GAAP gross margin of 46.7%–47.1% (second half stronger), operating expenses of $260–262 million (including roughly $10 million of adverse FX impact at current rates), and operating income of 0.7%–1.5% of revenue (H2 stronger). The company forecasts a GAAP net loss of $67–83 million, or $0.76–$0.95 per diluted share, versus non‑GAAP net income of $8–12.5 million, or $0.09–$0.14 per diluted share; adjusted EBITDA is expected at 4.5%–5% of revenue ($25–30 million), a range that includes about $17 million of combined FX and tariff headwinds. Capital expenditures are forecast at $20–25 million and Stratasys expects to deliver positive operating cash flow for the full year, subject to FX and tariff uncertainty.
Stratasys Financial Statement Overview
Summary
Financials are mixed: a very strong, low-leverage balance sheet provides flexibility, but multi-year revenue decline and continued GAAP losses weigh heavily. Operating cash flow has improved and turned positive recently, yet free cash flow remains negative, indicating the turnaround is not fully reflected in cash generation.
Income Statement
32
Negative
Balance Sheet
78
Positive
Cash Flow
45
Neutral
Breakdown
Dec 2025
Dec 2024
Dec 2023
Dec 2022
Dec 2021
Income Statement
Total Revenue
551.10M
572.46M
627.60M
651.48M
607.22M
Gross Profit
259.26M
256.82M
267.02M
276.47M
260.08M
EBITDA
-58.79M
-40.32M
-31.71M
2.61M
-23.07M
Net Income
-104.28M
-120.28M
-123.07M
-28.97M
-61.98M
Balance Sheet
Total Assets
1.07B
1.03B
1.13B
1.26B
1.28B
Cash, Cash Equivalents and Short-Term Investments
244.53M
150.70M
162.59M
327.84M
502.18M
Total Debt
26.50M
32.09M
18.66M
17.84M
14.97M
Total Liabilities
230.86M
236.75M
249.07M
300.36M
321.21M
Stockholders Equity
842.90M
792.99M
884.84M
959.43M
956.01M
Cash Flow
Free Cash Flow
-6.97M
-4.89M
-76.67M
-95.16M
9.07M
Operating Cash Flow
15.14M
7.83M
-61.65M
-75.41M
35.82M
Investing Cash Flow
-112.23M
-14.82M
-3.83M
-7.21M
-291.17M
Financing Cash Flow
117.97M
-3.31M
-1.52M
-2.77M
227.31M
Stratasys Technical Analysis
Technical Analysis Sentiment
Negative
Last Price7.91
Price Trends
50DMA
9.88
Negative
100DMA
9.56
Negative
200DMA
10.24
Negative
Market Momentum
MACD
-0.58
Negative
RSI
33.93
Neutral
STOCH
63.07
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SSYS, the sentiment is Negative. The current price of 7.91 is below the 20-day moving average (MA) of 8.44, below the 50-day MA of 9.88, and below the 200-day MA of 10.24, indicating a bearish trend. The MACD of -0.58 indicates Negative momentum. The RSI at 33.93 is Neutral, neither overbought nor oversold. The STOCH value of 63.07 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SSYS.
Stratasys Risk Analysis
Stratasys disclosed 53 risk factors in its most recent earnings report. Stratasys reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Stratasys Posts 2025 Loss but Improves Cash Flow and Margins, Issues 2026 Outlook
Mar 5, 2026
On March 5, 2026, Stratasys reported fourth quarter and full-year 2025 results showing revenue declines but improved profitability metrics on a non-GAAP basis. Fourth quarter revenue fell to $140 million from $150.4 million a year earlier, with a ...
Read more
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 08, 2026